Liquid crystalline coated drug particles as a potential route to long acting intravitreal steroids

Current Drug Delivery

Volumn 6, Issue 4, 2009, Pages 322-331

  Tilley, Adam ^a   Morton, David A V ^a   Hanley, Tracey ^b   Boyd, Ben J ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Controlled release; Cubic phase; Dissolution; Hexagonal phase; Intravitreal steroids; Liquid crystal; Liquid crystal coating; SAXS; Sustained release

Indexed keywords

LONG ACTING DRUG; NANOMATERIAL; SALICYLATE SODIUM; SALICYLIC ACID; STEROID; TRIAMCINOLONE ACETONIDE; TRIESENCE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG COATING; DRUG SOLUBILITY; DRUG TRANSPORT; LIQUID CRYSTAL; PARTICLE SIZE; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; SALICYLIC ACID; SODIUM SALICYLATE; SOLUBILITY; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 68949135417     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109789000564     Document Type: Article

References (19)

1. Cochereau, I. Endophthalmitis following new procedures. J. Francais D Ophtalmol., 2007, 30, 1067-1069.
2. Mansoor, S.; Kuppermann, B. D.; Kenney, M. C. Intraocular Sustained- Release Delivery Systems for Triamcinolone Acetonide. Pharmaceut. Res., 2009, 26, 770-784.
3. Drummond, C. J.; Fong, C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci., 1999, 4, 449-456. (Pubitemid 30449773)
4. Shah, J. C.; Sadhale, Y.; Chilukuri, D. M. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev., 2001, 47, 229-250. (Pubitemid 32324116)
5. Kumar M., K.; Shah, M. H.; Ketkar, A.; Mahadik, K. R.; Paradkar, A., Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int. J. Pharm., 2004, 272, 151-160. (Pubitemid 38293020)
6. Burrows, R.; Collett, J. H.; Attwood, D. The release of drugs from monoglyceride-water liquid crystalline phases. Int. J. Pharm., 1994, 111, 283-293. (Pubitemid 24292906)
7. Lee, K. W. Y.; Nguyen, T.-H.; Hanley, T.; Boyd, B. J. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int. J. Pharm., 2009, 365, 190-199.
8. Fong, W.-K.; Hanley, T.; Boyd, B. J. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J. Control. Release, 2009, 135, 218-226.
9. Clogston, J.; Rathman, J.; Tomasko, D.; Walker, H.; Caffrey, M. Phase behaviour of a monoacylglycerol (Myverol 18-99K)/water system. Chem. Phys. Lipids, 2000, 107, 191-220. (Pubitemid 30847617)
10. Nakano, M.; Teshigawara, T.; Sugita, A.; Leesajakul, W.; Taniguchi, A.; Kamo, T.; Matsuoka, H.; Handa, T. Dispersions of liquid crystalline phases of the monoolein/oleic acid/Pluronic F127 system. Langmuir, 2002, 18, 9283-9288. (Pubitemid 35458187)
11. Borne, J.; Nylander, T.; Khan, A. Phase Behavior and Aggregate Formation for the Aqueous Monoolein System Mixed with Sodium Oleate and Oleic Acid. Langmuir, 2001, 17, 7742-7751.
12. Lopes, L. B.; Ferreira, D. A.; de Paula, D.; Garcia, M. T. J.; Thomazini, J. A.; Fantini, M. C. A.; Bentley, M. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res., 2006, 23, 1332-1342. (Pubitemid 43946155)
13. Tanno, K. Production of Metal Ceramics Composite-Particles by Mechanofusion Process. 2 World Congress : Particle Technoly, Pts 1-5, 1990, C461-C468.
14. Kumon, M.; Suzuki, M.; Kusai, A.; Yonemochi, E.; Terada, K. Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC. Chem. Pharmaceut. Bull., 2006, 54, 1508-1514. (Pubitemid 44703976)
15. Begat, P.; Morton, D. A. V.; Price, R.; Staniforth, J. N. The Influence of Force Control Agents on the Adhesive-Cohesive Balance in Dry Powder Inhaler Formulations. KONA, 2005, 23, 109-121.
16. Hyde, S. T. Identification of lyotropic liquid crystalline mesophases. In Handbook of Applied Science and Colloid Chemistry, Holmberg, K., Ed. John Wiley & Sons Ltd.: New York, 2001; pp. 299-332.
17. Salama, R. O.; Traini, D.; Chan, H. K.; Young, P. M. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur. J. Pharmaceut. Biopharmaceut., 2008, 70, 145-152.
18. Block, L. H.; Patel, R. N. Solubility and dissolution of triamcinolone acetonide. J. Pharmaceut. Sci., 1973, 62, 617-621.
19. Zhao, F. Y.; Stewart, P. J., De-agglomeration of micronized benzodiazepines in dissolution media measured by laser diffraction particle sizing. J. Pharm. Pharmacol., 2003, 55, 749-755.